14th International Headache Congress: clinical highlights.
The 14th International Headache Congress was held in Philadelphia in September 2009. During the Congress, many important basic, translational, and patient-oriented research studies were presented. In this and an accompanying manuscript, the work that has been deemed to be among the most innovative and significant is summarized. This manuscript discusses the best clinical research, while the accompanying manuscript summarizes the top basic science research. Here, we provide background and summarize Congress presentations on novel agents for migraine treatment, botulinum toxin therapy for chronic migraine, new methods for administration of headache medications, and nerve stimulation for the treatment of medically refractory headaches.
Schwedt
Todd J
TJ
Washington University Headache Center, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Silberstein
Stephen D
SD
D000700:Analgesics / Q000302:isolation & purification / Q000494:pharmacology*; D035843:Biomedical Research / Q000639:trends*; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000379:methods / Q000639:trends; D004599:Electric Stimulation Therapy / Q000379:methods; D020773:Headache Disorders / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007391:International Cooperation; D009480:Neuropharmacology / Q000379:methods / Q000639:trends*; D015143:Philadelphia; D057170:Translational Research, Biomedical / Q000639:trends*; D016896:Treatment Outcome
D000700:Analgesics